Ani Pharmaceuticals, Inc
$1.63B- Market cap
- $1.60B
- Debt
- +$309.11M
- Cash
- −$285.59M
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIP · current priceP/E 21.46x
$71.25Latest market snapshot
Implied fair value · at REG's multiple
$86.7621.8% above market
3.32 ANIP EPS (TTM)×26.13x REG P/E=$86.76
Market $71.25Implied $86.76
REG · current priceP/E 26.13x
$75.28Latest market snapshot
Implied fair value · at ANIP's multiple
$61.8217.9% below market
2.88 REG EPS (TTM)×21.46x ANIP P/E=$61.82
Market $75.28Implied $61.82